Richard Sullivan is a Deputy Editor at various esteemed publications. He specializes in a diverse range of topics including arts and entertainment, culture and society, and healthcare, with a particular focus on radiation oncology, mental health care, and palliative care. Richard's insightful work has been featured in prominent outlets such as The Lancet, BMJ, and The Scotsman, among others.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Richard's focus is primarily on local crime and political issues, particularly related to organized crime and paramilitary groups in Ireland. He appears to be deeply immersed in evolving stories and breaking news within this domain.
Given the intense nature of the topics covered, those reaching out should ensure that they can provide accurate and reliable information about ongoing events or have expertise in Irish politics, law enforcement, or criminal justice. Additionally, sources with firsthand knowledge of the situations being reported would likely resonate well with Richard’s coverage.
This information evolves through artificial intelligence and human feedback. Improve this profile .
£5.4m policing bill as Translink counts £1.5m bus carnage
By: Richard Sullivan
Far-right agitator Richard Inman brands Northern Ireland ‘most patriotic’ region of UK
By: Richard Sullivan
Families burnt out for no reason other than their religion, now we have families burnt out for no reason other than the colour of their skin.
By: Richard Sullivan
European Court of Human rights ruling hands Orange Order shock lifeline for lightning-rod parade
By: Richard Sullivan
When Prince Harry called up a bunch of celebrity pals and decided to sue the Daily Mail it was accepted and assumed to onlybe a question of how much.
By: Richard Sullivan
Enrique Tarrio and Proud Boys militants who stormed White House are ‘touring' loyalist Belfast in race riot documentary stunt
Fury as terror gang member blamed for John Steele death welcomed home A UDA man blamed for causing the death of Larne bonfire builder John Steele has returned from self-imposed exile.
By: Richard Sullivan
The cheeky flag is believed to have emerged in the loyalist area in south Belfast in recent times
Investment in innovative drugs must not come at the expense of wider cancer servicesIn June 2026, several media channels published pictures of delegates at the American Society of Clinical Oncology conference applauding the announcement of the trial results for daraxonrasib, a new “game changer” drug for pancreatic cancer.1 Some may have greeted the claim with cynicism; new therapies and devices are often lauded as game changers by industry and academic institutions, but in reality achieve small or insubstantial benefits.2 However, in this case, the phase 3 trial showed substantial clinically meaningful benefit. The drug doubled survival compared with standard second line chemotherapy (on average, 13.2 months versus 6.7 months).3This is undoubtedly good news for patients given that there have been limited gains in the past 20 years in previously treated pancreatic cancer.4 However, the broader outlook for pancreatic cancer remains poor. The UK National Pancreatic Cancer Audit has shown that four in five patients with newly diagnosed pancreatic cancer will not be alive at 1 year.5 A trial testing KRAS inhibitors as firstline treatment in patients with metastatic pancreatic cancer is due …
By: Richard Sullivan
Proud Boys chief Enrique Tarrio brands the North as the ‘frontline in cultural reckoning' in riot film
